Artia Global Partners »

Sionna Therapeutics shares owned by Artia Global Partners

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 120k 41.14

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Viking Global Investors
Atlas Venture Life Science Advisors
Enavate Sciences GP
Jpmorgan Chase & Co
BlackRock
Vanguard Group
Perceptive Advisors
Jennison Associates
Deerfield Management Company
Standard Life Aberdeen
State Street Corporation
Eventide Asset Management

View all funds holding Sionna Therapeutics